Clinical trial · Interventional
A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): The standard measures of anaesthesia in cystoscopy are not uniform internationally, and given this, we were unable to recruit the first participant in the study.
Summary
Brief summary (as posted)
The goal of this clinical trial is to learn about a novel application of lidocaine injection in male patients who needs rigid cycstoscopy test. The main question it aims to answer is:Does New Application of Lidocaine Liquid Provide Pain Relief for Patients During Cystoscopy? Before the cycstoscopy,Participants will be randomly divided into three different anesthesia mode groups,namely are Group A (intraurethral lidocaine gel alone), Group B (intraurethral lidocaine gel + lidocaine 2% injection), and Group C (intraurethral lidocaine gel + liquid paraffinl).Patients only need to prepare and cooperate according to routine surgical operations，which is group B or group C.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Intraurethral lidocaine gel alone | Drug | — | UNRESOLVED |
| Intraurethral lidocaine gel + lidocaine 2% injection | Drug | — | UNRESOLVED |
| intraurethral lidocaine gel + liquid paraffinl | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- SHAM_COMPARATOR
- label
- Intraurethral lidocaine gel alone
- description
- Participants received 10 ml of intraurethral lidocaine gel at a concentration of 2%
- interventionNames
- Drug: Intraurethral lidocaine gel alone
- type
- EXPERIMENTAL
- label
- Intraurethral lidocaine gel + lidocaine 2% injection
- description
- Participants received 10 ml of intraurethral lidocaine gel at a concentration of 2% and using the injection of lidocaine 2% to irrigate the urethra using a 20 ml syringe.
- interventionNames
- Drug: Intraurethral lidocaine gel + lidocaine 2% injection
- type
- EXPERIMENTAL
- label
- intraurethral lidocaine gel + liquid paraffinl
Eligibility
Eligibility (as posted)
- Sex
- Male
- Maximum age
- 50 Years
Show eligibility criteria text
Inclusion Criteria: * Male patients under the age of 50 referred for postoperative cystoscopy for bladder cancer Exclusion Criteria: \- 1. Other evident causes contributing to lower urinary tract symptoms, such as obvious glandular cystitis and severe urinary tract infections. 2\. Excessive prostatic hyperplasia. 3. Urethral stricture. 4. A history of prior urethral surgeries. 5. Uncontrolled hypertension, cardiac conditions, and chronic obstructive pulmonary disease.
References
Publications (0)
Data not yet available